Literature DB >> 17007956

Coping strategies in immigrant men and women with type 2 diabetes.

Catharina Gåfvels1, Per Eric Wändell.   

Abstract

The aim of this study was to assess coping strategies of foreign-born men and women with type 2 diabetes in relation to demographic (sex, age, time in Sweden), medical, and socio-economic situation, and as compared with Swedish-born patients. Participants were foreign-born type 2 diabetic patients of European and non-European origin in primary health care in Stockholm County, comprising 41 men and 36 women aged 35-64 years, compared with Swedish-born type 2 diabetes patients, 121 men and 111 women. The General Coping Questionnaire, which measures five main orientations, dichotomised into "positive" and "negative" factors, i.e. 10 coping strategies, was used in the assessment. Medical and socio-economic data were obtained from medical records and postal questionnaires. Foreign-born men showed an impact on 6 of 10 coping strategies, and foreign-born women on 2 of 10 coping strategies, as compared to Swedish-born subjects. Longer time since migration and higher educational level were associated with lower scores for stressful coping strategies, while having financial problems and receiving a disability pension were associated with higher scores. In conclusion, the most stressful coping strategies were found among foreign-born men. It seems to be essential to improve and adjust diabetes care for immigrants, also including the psycho-social perspective.

Entities:  

Mesh:

Year:  2006        PMID: 17007956     DOI: 10.1016/j.diabres.2006.09.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Coping Strategies in Patients Who Had Suicide Attempts.

Authors:  Ramazan Konkan; Gizem Hanzade Erkuş; Oya Güçlü; Ömer Şenormanci; Erkan Aydin; Mine Cansu Ülgen; Mehmet Z Sungur
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

2.  Psychosocial problems among newly diagnosed rheumatoid arthritis patients.

Authors:  C Gåfvels; M Hägerström; B Nordmark; P E Wändell
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

3.  Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway.

Authors:  Anh T Tran; Lien M Diep; John G Cooper; Tor Claudi; Jørund Straand; Kåre Birkeland; Wibeche Ingskog; Anne K Jenum
Journal:  BMC Health Serv Res       Date:  2010-05-28       Impact factor: 2.655

4.  To be an immigrant and a patient in Sweden: A study with an individualised perspective.

Authors:  Elisabeth Björk Brämberg; Maria Nyström
Journal:  Int J Qual Stud Health Well-being       Date:  2010-10-18

5.  Health-Related Quality of Life, Subjective Health Complaints, Psychological Distress and Coping in Pakistani Immigrant Women With and Without the Metabolic Syndrome : The InnvaDiab-DEPLAN Study on Pakistani Immigrant Women Living in Oslo, Norway.

Authors:  Victoria Telle Hjellset; Camilla M Ihlebæk; Benedikte Bjørge; Hege R Eriksen; Arne T Høstmark
Journal:  J Immigr Minor Health       Date:  2011-08

6.  What predicts negative effects of rheumatoid arthritis? A follow-up two years after diagnosis.

Authors:  Catharina Gåfvels; Margareta Hägerström; Birgitta Nordmark; Per Wändell
Journal:  Springerplus       Date:  2014-02-28

7.  Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis.

Authors:  Catharina Gåfvels; Margareta Hägerström; Kristina Rane; Alexandre Wajngot; Per E Wändell
Journal:  Health Psychol Open       Date:  2016-11-15

8.  Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.

Authors:  Anh T Tran; Jørund Straand; Ingvild Dalen; Kåre I Birkeland; Tor Claudi; John G Cooper; Haakon E Meyer; Anne K Jenum
Journal:  BMC Health Serv Res       Date:  2013-05-20       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.